Medical Health & Life Science Research News

Research delivers insight into the Global radiopharmaceutical market forecast 2017-2022

Medical Market Research

Global Radiopharmaceutical Market by Application, Manufacturers, Regions, Type and Forecast to 2022 is a professional and in-depth study on the current state of the Radiopharmaceutical industry. The Radiopharmaceutical market analysis is provided for the international market including development history, competitive landscape analysis, and major regions development status.

- Advertising -

119 pages report available @…cast-to-2022.html.

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule.

The organic molecule conveys the radioisotope to specific organs, tissues or cells.

- Advertising -

The radioisotope is selected for its properties.

Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Scope of the Report:

This report focuses on the Automated Biochemical Analysers in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

 Browse “Global Radiopharmaceutical Market by Manufacturers, Countries, Type and Application, Forecast to 2022” report at….aspx?name=953087.

This Report Covers Market Segment by Manufacturers is as: Bayer, Triad Isotopes, Lantheus, GE Healthcare, Mallinckrodt, Eli Lilly, Bracco Imaging, SIEMENS, Navidea, Nordion, IBA Group and Jubilant Pharma

Market Segment by Regions, regional analysis covers:

  • North America (USA, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Columbia.)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Global Radiopharmaceutical Market Segment by Type:

  • SPECT Radioisotopes
  • PET Radioisotopes
  • Other Diagnostic Radioisotopes
  • Therapeutic Radioisotopes

Market Segment by Applications, which can be divided into:

  • Oncology
  • Cardiology
  • Other

Get Report @

There are 15 Chapters to deeply display the global Radiopharmaceutical market.

Chapter 1: Describe  Radiopharmaceutical Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2: Analyze the top manufacturers of  Radiopharmaceutical, with sales, revenue, and price of  Radiopharmaceutical, in 2016 and 2017;
Chapter 3: Display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4: Show the global market by regions, with sales, revenue and market share of  Radiopharmaceutical, for each region, from 2012 to 2017;
Chapter 5, 6, 7, 8 and 9: Analyze the key regions, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11: Show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;
Chapter 12: In Chapter Eleven  Radiopharmaceutical market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;
Chapter 13, 14: Describe  Radiopharmaceutical sales channel, distributors, traders, dealers, appendix and data source. 

News From

ReportsnReports - Industry Trends & ForecastsReportsnReports
Category: Market Research Publishers and RetailersCompany profile: provides market research reports to industries, individuals and organizations with an objective of helping them in their decision-making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets.